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The pervasive transcription of the genome creates many types of non-coding RNAs (ncRNAs). However, we know very little 
regarding the functions and the regulatory mechanisms of these ncRNAs. Exploring the interactions of RNA and RNA binding 
proteins (RBPs) is vital because it can allow us to truly understand how these ncRNAs behave in vivo. High-throughput se-
quencing of RNA isolated by cross-linking immunoprecipitation (HITS-CLIP or CLIP-seq) and its variants have been suc-
cessfully used as systemic techniques to study RBP binding sites. In this review, we will explain the major differences between 
the CLIP techniques, summarize successful applications of these techniques, discuss limitations of CLIP, present some sug-
gested solutions and project their promising future roles in studying the RNA world. 
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The ENCODE (Encyclopedia of DNA Elements) project 
indicated that approximately 75% of the genome are cov-
ered by primary transcripts and 62% by processed tran-
scripts [1], while only 2% encode for proteins [2]. This vast 
disparity indicates that there are many types of non-coding 
RNAs (ncRNAs). Recently, some small ncRNAs, such as 
microRNA, piRNA and siRNA, have attracted attention and 
some progress has occurred. The function and the regulato-
ry mechanisms of these ncRNAs have been illustrated. 
However, for some types of ncRNA, such as long non- 
coding RNAs (lncRNAs), their roles and functional mecha-
nisms are poorly understood. Moreover, due to a lack of 
similar mechanisms of action and sequence conservation, it 
is very challenging to fully master these ncRNAs. Investi-
gations of these and other newly identified ncRNAs will be 
important work in the next decade. 
The biogenesis and the maturation of RNAs are regulated 
by many proteins. Moreover, RNA and RNA binding pro-
teins (RBPs) usually form RNA-protein complexes to func-
tion together. Some types of RNAs, for example, piRNA 
(Piwi-interacting RNA), are named after the corresponding 
binding protein. Therefore, investigating the physiological 
functions of RBPs and their interactions with RNAs will be 
of help in understanding the RNA world. The dynamic 
combination, competition and collaboration between RNA 
and RBPs offers many opportunities to explore the func-
tions and mechanisms of action of these RNAs [3]. Many 
biochemical technologies are invented to explore interac-
tions between RNAs and RBPs. Recently, a method known 
as cross-linking immunoprecipitation (CLIP), and modified 
forms of this method, such as photoactivatable-ribonucleo- 
side-enhanced cross-linking and immunoprecipitation 
(PAR-CLIP), individual-nucleotide resolution cross-linking 
and immunoprecipitation (iCLIP), cross-linking and analy-
sis of cDNAs (CRAC) and cross-linking, ligation, and se-
quencing of hybrids (CLASH), have been successfully used 
76 Zhang Y, et al.   Sci China Life Sci   January (2015) Vol.58 No.1 
in decoding RNA-protein interactions. In this review, we 
describe the procedures, discuss the differences between 
each protocol, illustrate some classical cases and discuss 
possible improvements and applications of these methods. 
1  The development and modifications of CLIP 
Many biochemical technologies are invented to study the 
interactions between RNAs and RBPs. The most widely 
used strategy is purification of RNA-protein complexes 
through different methods by pulling down either RNAs or 
proteins. RNA immunoprecipitation (RIP) is extensively 
employed to identify the interactions between RNAs and 
proteins, and many commercial kits are available. However, 
this method also has many disadvantages; for example, 
producing high false positive products and an inability to 
pinpoint the sites of RNA-protein interactions [4,5].  
To overcome the intrinsic disadvantages of RIP, Darnell 
and co-workers [6,7] developed a complex protocol based 
on RIP, named UV cross-linking and immunoprecipitation 
(CLIP). Then, they combined emerging high-throughput 
sequencing with CLIP and named the technique HITS-CLIP 
[8,9]. They improved the RIP protocol in three ways. First, 
the samples, either tissues or cells, are cross-linked by UV 
irradiation. UV cross-linking produces covalent bonds be-
tween RNA and protein, which allows stringent purification 
and increasing the signal-to-noise ratio in the following 
steps. Compared to formaldehyde cross-linking, which is 
usually used in chromatin immunoprecipitation (ChIP), the 
UV cross-linking does not induce large multi-molecular 
chemical bridges and only cross-links direct nucleic ac-
id-protein interactions (within Ångstrom distances) [10]. 
Second, RNase digestion was introduced to the protocol. 
Because free RNAs are much more sensitive to RNase than 
protein-bound RNAs, moderate RNase digestion can digest 
the unbound parts of RNA and reserve the protein binding 
sites of RNA. The fragmentation of RNAs makes it con-
venient to perform sequencing and motif analysis, in addi-
tion to avoiding pulling down undesirable protein-RNA- 
protein complexes. Third, rigorous purification, such as 
multiple  washings between each reaction, SDS-PAGE and 
transfer to nitrocellulose membrane were added. These steps 
can help to remove the non-specific binding proteins for the 
antibody, and eliminate unbound and non-cross-linked 
RNAs, which will decrease the background of the data. 
After successfully using HITS-CLIP to decode the 
RNA-protein interactions of Nova and Argonaute [6,8,9], 
many modified versions of CLIP have been developed. 
Among them, PAR-CLIP is the most widely used. The 
PAR-CLIP protocol employs ribonucleoside analogs, such 
as 4-thiouridine (4SU) and 6-thioguanosine (6SG), which 
can be selectively photoactivated at long wavelength UV  
(>320 nm), to enhance cross-linking between nucleic acids 
and proteins [11]. 4SU is the preferred option because it has 
higher cross-linking efficiency [12] and uridines are the 
most frequent cross-linking sites [13]. The incorporation of 
4SU into RNAs results in thymidine (T) to cytidine (C) 
transitions during the RT reaction, which is a good indicator 
of binding sites and can be used to subtract non-cross-  
linking background signals [14]. The addition of 4SU to 
PAR-CLIP also results in some limitations. To incorporate 
4SU into  nascent RNAs, it must be added to the medium, 
which is not possible for most model animals or clinical 
specimens. Moreover, although the mRNA profile is almost 
unchanged after adding 4SU [12], there are some reports 
showing that 4SU is toxic to cells [1517]. 
Another variant is individual-nucleotide resolution UV 
cross-linking and immunoprecipitation (iCLIP). This pro-
tocol was designed to acquire information of cross-linking 
sites at a single nucleotide resolution [18]. The amino acid 
residues at the cross-linking sites are barriers to the RT re-
action, which often results in mutation and deletion, and 
may even stop the RT reaction [17,19]. These mutation and 
stop sites can provide information regarding the cross- 
linking sites [5]. However, because amplification of cDNAs 
depends on 5′ and 3′ adaptor sequences, cDNAs lacking 5′ 
adaptors, which are caused by incomplete RT, cannot be 
amplified by classical cloning strategies. The iCLIP proto-
col introduces a 5′ linker by circularization of cDNA and 
restriction enzymes, which bypasses the limitation of a lack 
of a 5′ linker due to incomplete RT (Figure 2).  
The CRAC and CLASH methods employ affini-
ty-purification of tagged proteins rather than immunopre-
cipitation of endogenous proteins [2022]. CLASH is an 
improved version of CRAC. The most important improve-
ment is ligation of base-paired RNA molecules and the 
generation of chimeric RNAs. RNA guiding is a commonly 
used mechanism for many types of RNAs, such as miRNA, 
piRNA and snoRNA [23], and the search for targets of these 
RNAs is a challenge [24]. The chimeric RNAs generated by 
CLASH can detect direct, high-throughput mapping of 
RNA-RNA interactions and thus provide an excellent solu-
tion for target searching. 
The major differences, advantages and disadvantages of 
these different versions of CLIP are summarized in Table 1. 
2  Key steps of the CLIP protocol 
Because the detailed protocols of each version of CLIP are 
illustrated clearly in the original studies, methodological 
special issues and reviews (Table 1). Here, we do not in-
clude protocol details but instead focus on the different 
strategies adopted by different variants of CLIP in each step. 
The bioinformatic analysis of CLIP data is also described 
here, and the available tools are summarized in Table 2. 
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Figure 1  CLIP as an excellent tool for functional RNomics study. CLIP provides useful information of RNA-RBP interactions, RPB regulatory elements 
and RNA-RNA interactions. Integrated analysis of this information can help researchers to understand the function and regulatory mechanism of RNAs, 
especially novel ncRNAs. 
Table 1  Differences among CLIP variants 
Protocol name Major modification Advantages and disadvantages References 
HITS-CLIP Original version of CLIP 
Can apply to both tissue and cell; no potential toxicity to cell 
compared to PAR-CLIP 




Use 4SU to enhance cross-link 
efficiency 
Higher cross-linking efficiency; T to C mutation as a indicator 
of binding sites 
Can only apply to cell line; potential toxicity to cell 
[12,13] 
iCLIP 
Use a new strategy to clone incomplete 
RT product due to cross-linking 




Use affinity-purification to isolate 
RNA-binding protein 
Have no restriction of antibody; can be applied for non-model 
organism 
The tag and overexpression of protein may have potential 
influence on the binding pattern between protein and RNA 
[20] 
CLASH 
Use affinity-purification to isolate 
RNA-binding protein; 
conduct intermolecular RNA-RNA 
ligation 
The formation of chimeric RNAs is a very useful imformation 
for RNA that function as a guider such as miRNA and snoRNA 
The tag and overexpression of protein may have potential 
influence on the binding pattern between protein and RNA 
[21,22] 
 
2.1  Sample preparation and UV cross-linking 
The samples used for UV cross-linking must be fresh, and 
cryopreservation can only be performed after UV 
cross-linking. For PAR-CLIP, a final concentration of 100 
μmol L1 of 4SU should be added into the medium 14 h 
before cross-linking, and then 365 nm UV was selected to 
cross-link RNA-protein complex. Except for PAR-CLIP, 
254 nm UV is used to cross-link the RNA-protein com-
plexes. Tissues should be homogenized or triturated before 
the UV cross-linking. The strength of the UV cross-link 
should be optimized; tissues usually require higher energy 
levels than cells. The UV cross-linked sample can be either 
processed to the next step or shock-frozen in liquid nitrogen 
and stored at 80°C for up to one year [9,26]. 
2.2  Cell lysis and RNase digestion 
Newly cross-linked or frozen samples are lysed in cooled 
lysis buffer for approximately 30 min. The composition of 
the lysis buffer may differ among the methods. The key 
components are Tris-HCl or PBS buffer, detergent and pro-
tease inhibitors. After cell lysis, RNase is added to the lysis 
buffer. For HITS-CLIP and iCLIP, DNase is also added 
before RNase digestion. However, for PAR-CLIP, CRAC 
and CLASH, the DNase digestion is omitted. different 
RNase such as RNase A [9], RNase T1 [12], and RNase I 
[27] are used in different laboratories. RNase A specifically 
cleaves single-stranded RNA at C and U residues and 
RNase T1 at G residues; RNase I has no biases. To mini-
mize biases caused by RNase, a mixture of RNase A and T1 
is used in CRAC and CLASH, and the RNA digestion is 
performed on beads rather than in lysis buffer [2022]. The 
concentration of RNase and the time of digestion should be 
determined to obtain RNA fragments of the appropriate 
length.  
2.3  Immunoprecipitation 
For HITS-CLIP, PAR-CLIP and iCLIP, immunoprecipita-
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Table 2  Available software or database for CLIP 
Name Implementation Application Features References 
PARalyzer C/C++ PAR-CLIP 
Utilizes kernel density estimations to distinguish T to C muta-
tions signal and background and thus identify binding sites 
[14] 
wavClusteR R package PAR-CLIP Use nonparametric mixture models to identify binding sites [45] 
rcpphmmparclip R package PAR-CLIP 
Adopts non-homogeneous HMM and considers spatial depend-
ence of genomic locations 
[46] 
CIMS Perl/shell all CLIP variants 
Deletion and substitution are tracked to identify cross-linking 
sites 
[4,17] 
dCLIP Perl all CLIP variants Quantitative CLIP-seq comparative analysis [47] 
Piranha C/C++ all CLIP variants 
Peak-calling tool that can allows consideration of transcript 
abundance, direct comparison of site usage across cell-types or 
conditions 
[32] 
ASPeak Perl all CLIP variants Peak-calling tool that can used in CLIP and RIP [48] 
RIPSeeker R package all CLIP variants De novo peak predictions based on HMM [34] 
CLIPper Python all CLIP variants 
https://github.com/YeoLab/clipper/wiki/CLIPper-Home 
A tool for defining peaks of CLIP data 
 
CapR C/C++ all CLIP variants Prediction secondary structure of RBPs binding motif [39] 
GraphProt Perl all CLIP variants 
Provides motif search, structure analysis and diverse funtions 
like predicting RBP affinities and scanning for RBP target sites 
[40] 
PIPE-CLIP Galaxy server all CLIP variants 
An online pipeline to process and analyze CLIP-seq data which 
allows user-specified parameters 
[49] 
CLIPZ Web server all CLIP variants 
Provides database and analysis environment for analyzing and 
visualizing CLIP-seq data 
[41] 
doRiNA Web server all CLIP variants 
Database stores and integrates CLIP data for RBPs and miR-
NAs, visualized by local copy of the UCSC genome 
browser 
[42] 
starBase Web server all CLIP variants 
Database provides RBPs binding sites, integrated ncRNAs anal-
ysis and Pan-Cancer analysis based on comprehensive CLIP 




tion is used to purify the RNA-protein complex, so the 
choice of antibody is vital. Because many antibodies used 
for Western blotting perform poorly in immunoprecipitation, 
and the specificity of antibodies varies under different con-
ditions, pre-testing the antibodies under the same conditions 
of CLIP is strongly recommended. Immunoprecipitation of 
endogenous or tagged protein and silver staining can be 
used to detect the antibodies. The antibodies are pre-   
incubated with Dynabead-coupled protein A or G to immo-
bilize them. For CRAC and CLASH, the protein is fused to 
a His6-TEV-Protein A tag; the protein is first purified by 
IgG coupled on beads and then by Ni-NTA affinity chro-
matography. 
2.4  Radiolabeling of RNA, SDS-PAGE and transfer to 
nitrocellulose  
To visualize the band of RNA-protein complex in gel or 
nitrocellulose membrane, RNAs or linkers are radiolabeled. 
For HITS-CLIP and iCLIP, 3′ linkers are radiolabeled and 
then ligated to RNAs on beads. As for PAR-CLIP, CRAC 
and CLASH, radiolabeling is carried on RNAs in the 
RNA-protein complex. After radiolabeling, the samples are 
denatured and separated by SDS-PAGE. The RNA-protein 
complexes are then transferred to nitrocellulose membranes, 
exposed on film to visualize the complexes and cut the cor-
responding band. The transfer nitrocellulose membrane 
permeates free RNAs and detains RNA-protein complexes, 
which can reduce background. However, for PAR-CLIP, the 
transfer nitrocellulose is omitted; the gel is exposed on film, 
cut, and then electro-eluted.  
2.5  Isolation and cloning of RNA 
The nitrocellulose membranes or electroelution products are 
incubated with proteinase K to digest protein and release the 
RNAs. The RNAs are then recovered by phenol/chloroform 
extraction and precipitated by ethanol and glycogen. 
Re-dissolved RNAs are linked to adaptors and then re-
verse-transcribed. For this process, different CLIP methods 
take different strategies. For HITS-CLIP, the 3′ linker is 
added prior to SDS-PAGE on beads and the 5′ linker is 
added to the RNA. For iCLIP, the 3′ linker is already ligated 
to the beads and the RT primer contains two cleavable link-
er regions. After RT and size selection by urea-PAGE, cir-
cularization and restriction enzyme digestion are carried out. 
The two cleavable linker regions separate and became the 5′ 
linker and the 3′ linker. This ingenious cloning strategy by-
passes the blockages during the RT reaction. Moreover, the 
blocking site of RT can be a good indicator for cross-linking. 
For PAR-CLIP, CRAC and CLASH, the isolated RNA is 
added to the 3′ linker and the 5′ linker and is re-
verse-transcribed. Many measures, such as blockage of the 
3′ linker, sequential dephosphorylation and phosphorylation, 
employment of truncated ligases, were adopted to avoid 
self-ligation and other undesired ligations in a different 
CLIP protocol. The cDNA is then amplified by PCR of 
proper cycles and then sent to undergo high-throughput se-
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Figure 2  The CLIP methods and their applications. A, The schematic illustrates the workflow of CLIP and differences of each method. B, Key steps of 
bioinformatic analysis of CLIP and the available tools. C, Examples of successful applications of CLIP. 
quencing. 
2.6  Bioinformatic analysis of CLIP data  
High-throughput sequencing using the CLIP procedure 
generates raw data that should be processed before further 
analysis.  Preprocessing of reads includes barcode splitting, 
quality filtering, and adaptor removal. Several tools are 
available to clean up raw sequencing data. FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) 
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provides the overall quality status of raw data, and the  
FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/)  
and PRINSEQ [28] are collections of command line tools 
for multiple preprocessing. 
Preprocessed data in FASTQ or FASTA format is then 
mapped to the genome or transcriptome. Because of inser-
tions and deletions caused by cross-linking, the software 
used for mapping should allow gaps. Algorithms such as 
BLAST+ [29], Novoalign (http://www.novocraft.com/main/ 
index.php), BWA [30] and Bowtie 2 [31] are capable of 
aligning gapped CLIP tags to the genome or transcriptome 
and report the position of mutations. For PAR-CLIP, more 
mismatches should be tolerated due to inherent T to C mu-
tations caused by 4SU. 
Overlapped tags are fused and the read coverage of each 
position is calculated. To distinguish between true binding 
sites and background caused by non-specific sequences, 
peak calling is required. There are some computer programs 
designed for peak-calling of ChIP-seq, but they are not 
suitable for CLIP due to intrinsic differences between 
ChIP-seq and CLIP. Programs such as Piranha [32], Pyicos 
[33], and RIPSeeker [34] were developed to solve this 
problem. PARalyzer [14] takes advantage of T to C muta-
tions to identify cross-linking sites of PAR-CLIP data. To 
find features of binding sites, motif searching is usually 
conducted. Algorithms such as MEME [35],  GMS [36], 
AlignACE [37] and RSAT [38] can be used to identify mo-
tifs within CLIP data. Recently, tools specifically designed 
for motif and structure analysis of CLIP have been devel-
oped [39,40].  
There are also some databases that allow for collecting 
and visualizing CLIP data, such as CLIPZ [41], doRiNA 
[42] and starBase [43,44]. StarBase v 2.0 is the most com-
prehensive CLIP database, which integrates 108 CLIP-Seq 
(HITS-CLIP, PAR-CLIP, iCLIP, CLASH) datasets of dif-
ferent RBPs. In addition to RNA-protein interactions,  
miRNA-lncRNA, miRNA-mRNA, miRNA-circRNA, miRNA-  
pseudogene, miRNA-sncRNA interactions, competing en-
dogenous RNA (ceRNA) networks, miRNA function and 
ceRNA function based on CLIP data are also available. In 
the recently updated version, it also provides Pan-Cancer 
Networks of lncRNAs, miRNAs, ceRNAs and RNA-  
binding RBPs by mining clinical and expression profiles of 
14 cancer types (>6000 samples) from The Cancer Genome 
Atlas (TCGA) Data Portal. 
For convenient analysis of CLIP data, we summarize the 
available tools and databases especially developed for CLIP, 
as well as their implementation, applications and main fea-
tures in Table 2. 
3  Successful applications of CLIP technology 
Since its development, over 300 studies using CLIP have 
been published [4]. Collecting CLIP data for each RBP 
could provide a genome-wide RNA-protein interaction map 
and thus largely promote studies in the field. 
3.1  Decoding miRNA-target interactions  
The most successful and extensive applications of CLIP are 
identifying miRNA targets. miRNAs are approximately 22 
nt non-coding RNAs that play important roles in regulating 
gene expression, primarily at the post-transcriptional level 
[50,51]. Although many studies have explored their func-
tions in proliferation, differentiation, and development, as 
well as pathologies such as tumorigenesis, the identification 
of miRNA targets remains a challenge [24,50]. Many algo-
rithms, mainly based on complementarity of “seed regions” 
and conservation of 3′ UTRs, have been developed to pre-
dict miRNA targets [52–54]. High false-positive rates and 
different performances of each program [51,55,56] are ma-
jor problems for bioinformatic prediction of miRNA-target 
interactions. High-throughput and experimental identifica-
tion of physiological targets and their binding sites is ur-
gently needed.  
The first report of this type of work is from 2009 [9], de-
scribing the analysis of an Ago2-miRNA-mRNA ternary 
complex in mouse brain using HITS-CLIP. Combined with 
bioinformatic analysis, thousands of miRNA-targets were 
identified.  The specificity, false-positive and false-negative 
rates were approximately 93%, 13%–27% and 15%–25%, 
respectively, estimated by comparing previously identified 
targets of miR-124. 
Markus et al. [12] studied all four human Ago proteins 
by PAR-CLIP in  HEK293 cells that stably express tagged 
Ago proteins. They obtained approximately 4000 over-
lapped clusters of each Ago protein, and found that human 
Ago14 have similar binding patterns. The mRNA abun-
dance of identified targets was statistically significant, de-
creasing after overexpression of miRNAs, which agreed 
with the observation that miRNAs cause destabilization of 
targets. 
The existing algorithms for miRNA target prediction are 
mostly based on a perfect match at a “seed region”. How-
ever, a previous structural study of a ternary complex of T. 
thermophilus Ago indicated that the mismatches and bulges 
in the seed region could be tolerated [57]. Another study 
suggested that these non-canonical sites were quite rare 
(less than 2% of all preferentially conserved sites) [58]. Ago 
CLIP makes it possible for the first time to systematically 
identify these non-canonical targets of miRNA. By analyz-
ing Ago HITS-CLIP “orphan clusters,”  Sung et al. [59] 
identified a type of non-canonical seed match: G-bulge sites, 
which comprise 15% of all Ago-miRNA interactions in 
mouse brain. By carrying out HITS-CLIP for miR-155 in 
wild type and knockout T cells, Gabriel et al. [60] systemi-
cally identified non-canonical targets of miR-155. For 
CLASH, the chimeric RNAs provide direct evidence of 
RNA-RNA interaction. This information is extremely valu-
able for studying miRNA targets, especially non-canonical 
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targets. Using the CLASH method,  Aleksandra et al. re-
ported over 18000 miRNA-target interactions, and found 
that approximately 60% of seed interactions are 
non-canonical [22]. Today, there are several tools identify-
ing non-canonical targets that take advantage of CLIP data 
[6163]. Decoding these non-canonical targets will expand 
our knowledge of miRNA, especially its  target recognition 
mechanisms.  
The properties of miRNA make it an ideal tool for virus-
es to regulate the gene expression of host cells. More than 
200 viral miRNAs have been identified. These viral miR-
NAs can target their own mRNAs, as well as host cell 
mRNAs. Cellular miRNAs can also target viral mRNAs 
[64,65]. Moreover, some viral miRNAs are orthologs of 
cellular miRNAs. For example, KSHV miR-K12-11 is an 
ortholog of miR-155, and they share the same seed se-
quence [66]. The miRNA-mRNA relationships between 
viruses and host cells, and their role in the regulation of 
infection and latent/lytic switching are quite intriguing, and 
can serve as an excellent model to investigate host-virus 
coevolution. To uncover the roles of miRNAs in host-virus 
interactions, the identification of bona fide targets is vital. 
Several reports employing CLIP to comprehensively under-
stand these questions have been published, including KSHV 
[67,68] and  EBV [69,70]. In each study, 5002000 targets 
of viral miRNAs were identified. These reports increase our 
knowledge of the function of viral miRNA. 
Embryonic stem cell (ESCs)-specific miRNAs play crit-
ical roles in establishing the stemness of ESCs [71]. The 
miRNAs that are specifically or highly expressed in ESCs 
can also reprogram mouse and human somatic cells to iP-
SCs alone or with the help of transcription factors [7274]. 
Various reports indicated that miRNAs are a key regulator 
of cell fate decision and conversion [75,76]. Although some 
important targets of these ESCs-enriched miRNAs have 
been revealed, many others remain to be identified. Leung 
et al. [77] conducted Ago2 CLIP in wild type mouse ESCs 
(mESCs) and Dicer−/− mESCs. They reported that the 
GCACUU motif, corresponding to the most highly ex-
pressed miRNA family, was significantly enriched in 
wild-type mESCs 3′ UTRs, but not in Dicer−/− mESCs. 
Many validated and novel targets of mESC-enriched miR-
NAs were identified. Human ESCs (hESCs) were also in-
vestigated by PAR-CLIP [78]; hundreds of miR-302/367 
targets were identified. Combining the dynamic change in 
miRNA profile at different stages of differentiation in 
hESCs, the roles of miR-302/367 in modulating TGF and 
the BMP signaling pathway were revealed. 
Inquiries into disease-related miRNA-mRNA interac-
tions can help us to understand pathogenesis and provide 
potential therapeutic targets for the disease. The miR-17–92 
family is the first miRNA gene implicated in cancer [79]. 
By combining PAR-CLIP analysis of human B cells and 
experimental validation in B cell-specific miR-17–92 trans-
genic mice that developed lymphomas, Hyun et al. [80] 
reported that miR-17–92 acts as a powerful cancer driver 
via activation of multiple oncogenic pathways, such as 
PI3K and NFκB. HITS-CLIP performed on human brain 
samples revealed that many disease-associated SNPs are 
within the target sites of brain-specific miRNAs, which in-
dicated that these SNPs could result in disease by destroy-
ing miRNA-target interactions [81].  The imprinted 
DLK1-MEG3 gene region is associated with type 2 diabetes 
(T2DM). Using HITS-CLIP, Vasumathi et al. [82] identified 
disease-relevant targets of miRNAs in the DLK1-MEG3 
gene region, implying their roles in T2DM. 
3.2  Identifying RNA-binding sites of splicing regula-
tors 
RNA splicing is one of the most important post-      
transcriptional regulation mechanisms, and plays a critical 
role in diverse life activities. Alternative splicing makes a 
large contribution to the polymorphism of mature mRNAs 
and proteins. Dozens of RNA binding proteins are involved 
in the regulation of RNA splicing [83,84]. Apart from Ago 
proteins, splicing regulators are the most intensively studied 
proteins by CLIP. RNA binding patterns of Nova [6,8], 
PTBs [85,86], FOX2 [87], SFRS1 [88], TIA [89], MBNL1 
[90], Cugbp1 [91],  SRSF1/2 [92] and hnRNP proteins 
[18,93,94] have been investigated. 
In addition to exploring the interplay of RNA-protein and 
decoding their roles in splicing, there are also some unex-
pected discoveries made or inspired by CLIP analysis of 
these splicing regulators. For example, hnRNP A1 is a nu-
cleocytoplasmic shuttling RBP that functions in alternative 
splicing and other mRNA metabolism process. Although the 
regular roles of hnRNP A1 in mRNA processing are well 
studied [9597], only a few targets of hnRNP A1 have been 
identified. Using CLIP, Sonia et al. [98] obtained a ge-
nome-wide map of hnRNP A1 binding sites. Unexpectedly, 
they found that hnRNP A1 specifically binds the primary 
transcript of miR-18a at the stem loop region, rather than 
other miRNAs. Additional study revealed that hnRNP A1 
facilitates processing of miR-18a in as well as repression of 
targets. This unexpected finding indicated that some RBPs 
could function as co-regulators for a specific miRNA at the 
post-transcriptional level, which is a more flexible strategy.  
Another interesting finding revealed by CLIP data was 
reported by Fu and colleagues, who revealed that knock-
down of PTB can induce trans-differentiation of fibroblasts 
into functional neurons [99]. PTB (also known as hnRNP I), 
a well-characterized splicing suppressor, is downregulated 
during neural development, which coincides with an in-
creased expression of its NS-enriched homolog (hPTB). 
Based on CLIP data and previous results [85,100], they 
identified a PTB-regulated miR124-REST loop, in which 
the downregulation of PTB leads to relief of PTB-mediated 
blockage of miR-124 repression of the REST complex, and 
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thus promote many neuronal genes, finally inducing 
trans-differentiation into neuron cells. 
3.3  Studying epigenetic modification-associated RNAs  
Polycomb Repressive Complex 2 (PRC2) can induce the 
methylation of histone H3 on lysine 27 (H3K27 me3) and 
result in transcriptional gene silencing, which controls cell 
fate, development and tumorigenesis [101]. How PRC2s are 
recruited to the target region of the genome is unknown. 
Some studies showed that non-coding RNAs guide PRC2 to 
specific regions via interacting with SUZ12 or EZH2 
[102,103]. To systemically study the associated RNAs of 
PRC2, Guil et al. [104] and Syuzo et al. [105] conducted 
CLIP experiments on EZH2 in human colorectal cancer 
cells and mouse ES cells. In human colorectal cancer cells, 
EZH2 binds many intronic RNAs. However, in mouse ES 
cells, EZH2 preferentially binds the 5′ region of nascent 
RNAs. These results indicated that EZH2 might incorporate 
different types of RNAs in different cell types. 
Increasing evidence suggests that non-coding RNAs, in-
cluding small RNAs and long non-coding RNA, play im-
portant roles in epigenetic regulation [106,107]. Proteins 
that can bind both DNA and RNA are ideal candidates for 
transcriptional and/or epigenetic regulators, in an RNA- 
guiding manner. Like the multifunction protein EZH2, there 
are some well-studied DNA-binding proteins, such as DNA 
methylase [108], Smad [109],  p53 [110,111], and others 
[112], that bind RNAs. Similarly, some RBPs can also bind 
DNA [113115]. Further investigation of their DNA or 
RNA binding characteristics, meta-analysis ChIP and CLIP 
data for these proteins will become research hotspots in the 
future. 
CTCF is a well-known DNA binding protein which plays 
extremely important roles in higher-order chromatin organ-
ization and has great impacts on gene expression at ge-
nome-wide [116]. Recently, by using PAR-CLIP, Ricardo et 
al. [117] reported CTCF can bind a variety of RNAs in vivo. 
Moreover, they found CTCF can regulate p53 expression 
via binding Wrap53 RNA, which is an antisense transcript 
originating from the p53 locus. This discovery not only re-
vealed new regulatory mechanism of CTCF, but also pro-
vided a vivid example that DNA binding proteins also func-
tion as RBPs.     
3.4  Exploring roles of ceRNA  
The ceRNA hypothesis [118,119] highlights interactions 
among mRNAs, transcribed pseudogenes and long 
non-coding RNAs by competitive binding to microRNA 
responding elements (MREs). More and more evidence 
supports this hypothesis, which suggests that these ceRNAs 
play essential roles in development and tumorigenesis 
[120126]. The identification of ceRNAs by traditional 
miRNA-target prediction algorithms is challenging due to 
an incomplete understanding of targeting rules [127].  
CLIP technology provides a good opportunity to study 
ceRNAs. A representative example was a type of circular 
RNA reported by Memczak et al. [128], which contains 63 
conserved sites of miR-7 that act as a “super sponge” for 
miRNA. This exciting discovery revealed “an important 
RNA that had flown under the radar” [129]. Another exem-
plary study was conducted by Libri et al. [130] using CRAC. 
They demonstrated that an OFR of murine cytomegalovirus 
(MCMV), m169, acted as a miRNA sponge and mediated 
the degradation of miR-27 in host cells. 
The integration of large-scale data from CLIP will give 
some clues for discovering new ceRNAs. StarBase, devel-
oped by our laboratory [43,44], provides the most compre-
hensive prediction of ceRNA networks, miRNA-lncRNA 
interactions and functions of lncRNAs based on CLIP data. 
4  Limitations and further improvements of 
CLIP 
Although CLIP performs quite well and is increasing in 
popularity, it has some limitations. For better applications of 
CLIP, we summarize the major defects and present some 
solutions. 
4.1  Reducing noise 
By rigorously washing and purifying, CLIP has much less 
background noise compared with RIP [5], but due to the 
extreme sensitivity of high-throughput sequencing, there are 
still background signals that cannot be ignored.  
Matthew et al. [131] reported that covalently cross-linked 
backgrounds were reproducible and most likely universal to 
PAR-CLIP procedures. This cross-linked background con-
tains T>C conversions and thus cannot be removed by bio-
informatic analysis alone. Because background reads are 
usually identical among libraries from different RBPs and 
different laboratories, they may be inherently introduced by 
some PAR-CLIP  processes and amplified by high- 
throughput sequencing. Moreover, it is reasonable that this 
cross-linked background also exists in other variants of 
CLIP. Negative controls, such as normal IgG or irrelevant 
proteins, can be used to efficiently subtract the background 
and are strongly recommended.  
Some background may result from contamination in sev-
eral steps. Commercial enzymes, such as ligase and pro-
teinase K, are recombinant and contain bacterial RNAs, 
which can be a source of contamination. These contami-
nants, most of which are rRNAs, cannot be completely ex-
cluded by alignment because some short bacterial rRNAs 
can also be aligned to the mammalian genome. In improved 
HITS-CLIP and iCLIP protocols, 3′ linker ligation is per-
formed on beads. Then, unbound bacterial RNA contami-
nants can be removed by washing, SDS-PAGE and nitro-
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cellulose transfer; the bacterial RNAs introduced after ni-
trocellulose transfer cannot be cloned due to lack of 3′ link-
er [7]. However, in the PAR-CLIP protocol, a 3′ adaptor is 
added to free RNA rather than the on-bead RNA; the bacte-
rial RNAs from proteinase K and ligase can also be cloned. 
Sixty percent to 80% of reads in PAR-CLIP cannot be 
mapped to the genome [132], which is much more than 
HITS-CLIP and iCLIP. Adopting the on-bead ligation 
strategy may improve the mapping rate and thus reduce the 
background for PAR-CLIP and CLASH.  
Biological replicates can be a good method for reducing 
false positives, and only clusters with good reproducibility 
should be considered potential RBP binding sites.  
4.2  Increasing RNA output efficiency  
A large bottleneck for CLIP is low RNA output efficiency, 
making it difficult to use CLIP to study low abundance 
RBPs. Low cross-linking efficiency and significant loss of 
RNAs during the experimental process are the causes.  
The cross-linking efficiency of HITS-CLIP is approxi-
mately 1%5% [5]. Although PAR-CLIP improves 
cross-linking efficiency by introducing 4SU or 6SG, its 
performance varies among different RBPs. Some BPS, such 
as HuR, have an efficiency similar to HITS-CLIP [13]. 
Searching high efficiency, low side effects cross-linking 
aids is in need for improving performance of CLIP. Meth-
ylene blue, which can increase dsRNA-protein cross-linking 
efficiency to 10%15% in visible light [133] and may pro-
vide an alternative photochemistry regent. Methods based 
on psoralen photochemistry to decode RNA-protein interac-
tions have been reported [134]. To utilize these regents in 
CLIP, pre-tests of toxicity, cross-linking efficiency and 
RNA recovery need to be conducted. 
CLIP achieves a high signal-to-noise ratio at the cost of 
RNA abundance, and only very small parts of the RNAs are 
reserved after rigorous purification. Thus, the purified 
RNAs are extremely precious and the  productivity of the 
clone procedure is vital. RNA ligation is the limiting pro-
cess of library preparation for CLIP. As mentioned above, 
HITS-CLIP and iCLIP add a 3′ linker to the beads. This 
strategy can reduce bacterial RNA contamination, but the 
ligation reaction may be suppressed on the beads. Wang et 
al. [27] reported that performing a 5′ adaptor ligation rather 
than a 3′ adaptor on beads can increase overall ligation effi-
ciency, primarily because 5′ adaptor ligation is more effi-
cient. Other improvements, such as using truncated T4 RNA 
ligase and adding PEG, have been introduced, and good 
performance of these strategies has been reported [135,136]. 
CLASH takes great advantage of intermolecular RNA-RNA 
ligation to explore RNA-RNA interactions directly. How-
ever, the intermolecular ligation efficiency is extremely low, 
approximately 2%. This low ligation efficiency, most likely 
caused by steric hindrance, hampers widespread use of 
CLASH. Attempts to overcome or improve this limitation 
should be made in the future. Recently, Grosswendt et al. 
[137] reported that intermolecular RNA-RNA ligation also 
occurred in the absence of the exogenous ligase and the 
chimeric RNA can also be found in HITS-CLIP and 
PAR-CLIP.   
4.3  Quantitative analysis 
Another limitation is the poor performance of quantitative 
analysis. Theoretically, the normalized CLIP read count is 
positively correlated to the amount of RNA bound to RBP, 
which reflects the affinity of the RNA-protein interaction. 
There are several factors that may bias read count among 
RNA ligation and PCR are the most determinant. Ligation 
efficiency varies dramatically, sometimes more than 
1000-fold, among RNA with different sequences and sec-
ondary structures. Some methods, such as high-efficiency 
RNA ligation and a pooled adapter strategy, have been em-
ployed to reduce the deviation introduced by ligation 
[136,138]. The barcode sequence in the RNA adaptor also 
contributes to the inequality of ligation efficiency. Intro-
ducing barcodes by PCR rather than in the RNA adaptor can 
efficiently reduce the bias [139].  
The non-linear amplification of PCR becomes another 
major source of quantitative inaccuracy in high-throughput 
sequencing. This problem becomes more serious when the 
low input RNA and requirement of more PCR cycles for 
CLIP is taken into consideration. Random sequence bar-
codes provide an ingenious way to remove PCR bias. Reads 
mapped to the same genome region with identical barcodes 
are regarded as the duplicates from a single RNA molecule 
and thus are counted as one. This strategy has been reported 
to greatly improve the quantification performance of CLIP 
[18,60,89,140]. Ion Torrent and Ion Proton sequencers re-
quire much less cDNA compared to Illumina sequencers. 
Fewer PCR cycles are accordingly needed, which may re-
duce non-linear amplification. Recently developed third 
generation sequencing requires no PCR and allows for di-
rect RNA sequencing [141], which gives a good prospect 
for quantitative analysis for CLIP. However, due to high 
read error rates, its performance in CLIP remains to be 
tested. Moreover, software such as dCLIP [47] has been 
developed to facilitate the quantitative analysis of CLIP. 
5  Conclusion and prospects 
The diverse types of RNAs and their spatial and tem-
poral-specific expression contribute greatly to the complex-
ity of life. In addition, the functions of non-coding RNAs 
are crucial for filling the gap between genotype and pheno-
type. Thus, the identification and functional study of new 
species of RNAs will be a momentous task for RNA re-
search. The booming growth of next generation sequencing 
and knowledge of the human genome offers numerous op-
84 Zhang Y, et al.   Sci China Life Sci   January (2015) Vol.58 No.1 
portunities to systematically identify novel non-coding 
RNAs. Querying the associated RBPs of these novel 
non-coding RNAs provides an optimal method to study 
their functions. CLIP and its variants are precise, and serve 
as a high-throughput method to decode RNA-protein inter-
actions, with excellent application prospect in studies of 
RNAs. 
Decoding RNA-protein interactions by CLIP provides a 
good perspective to explore the mysterious RNA world. 
However, only a few RBPs have been studied by CLIP, 
which are well characterized and functionally important. To 
further understand the RNA world, systematic identification 
and characterization of RBPs in the genome should be con-
ducted. Some preliminary work has been conducted 
[142144], and several hundred RBPs were identified. Fur-
ther characterization and CLIP study of these RBPs will 
yield valuable information. Recently, adenomatous polypo-
sis coli (APC), a microtubule plus-end scaffolding protein, 
was identified as an RBP by HITS-CLIP. Further analysis 
indicated that its associated RNAs were highly enriched for 
APC-related functions [145]. 
For functional study of RNAs by their associated RBPs, 
it is important to distinguish whether the protein is pro-
cessing-related or function-related. This task is challenging 
because our understanding of RBPs is limited, and pro-
cessing and function are sometimes coupled. Subcellular 
localization can also give some key clues to understanding 
the function of RBP and its associated RNAs. For example, 
many studies indicated that Ago proteins could locate in the 
nucleus and miRNAs could function in the nucleus 
[146149], but the targets of miRNA in the nucleus remain 
unknown. CLIP analysis of nuclear Ago may provide a 
global understanding of miRNA-target interactions. 
Some different RBPs can competitively or cooperatively 
bind the same RNA motif, and the binding of one RBP may 
change the RNA-protein interaction of others and thus in-
fluence the stability and function of RNAs. The interplay 
between the RISC complex and other RBPs and the impact 
on miRNA function have been studied [3,150]. Interestingly, 
a single RBP, HuR, can either facilitate [151] or attenuate 
[152] the combining of miRNA-RISC in the 3′ UTR of 
mRNA. The crosstalk between different RBPs adds a layer 
of complexity and flexibility to post-transcriptional regula-
tion. Integrating CLIP data from different types of RBPs 
will provide information on their interplay. 
To uncover the hidden RNA world, comprehensive usage 
of different aspects of information is vital. To this end, me-
ta-analysis of CLIP data, ChIP data, RNA expression pro-
files and other types of data from different cell types and 
physiological conditions will broaden our horizons in the 
RNA world. 
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